Regulation And Legal
Mahamaya Lifesciences Corporate Governance Exemption Q2 2026
Mahamaya Lifesciences declares non-applicability of SEBI corporate governance reporting requirements for Q2 2026.
The exemption applies as the company's shares are listed on BSE's SME platform under R